SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600
Income Statement
Earnings Waterfall
SciClone Pharmaceuticals (Holdings) Ltd
Revenue
|
3.2B
CNY
|
Cost of Revenue
|
-799.4m
CNY
|
Gross Profit
|
2.4B
CNY
|
Operating Expenses
|
-1.2B
CNY
|
Operating Income
|
1.2B
CNY
|
Other Expenses
|
-83.2m
CNY
|
Net Income
|
1.1B
CNY
|
Income Statement
SciClone Pharmaceuticals (Holdings) Ltd
Sep-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue |
3 162
N/A
|
1 919
-39%
|
3 250
+69%
|
2 518
-23%
|
2 662
+6%
|
2 750
+3%
|
2 878
+5%
|
3 156
+10%
|
|
Gross Profit | |||||||||
Cost of Revenue |
(682)
|
(428)
|
(713)
|
(585)
|
(641)
|
(679)
|
(747)
|
(799)
|
|
Gross Profit |
2 481
N/A
|
1 490
-40%
|
2 536
+70%
|
1 933
-24%
|
2 021
+5%
|
2 070
+2%
|
2 131
+3%
|
2 356
+11%
|
|
Operating Income | |||||||||
Operating Expenses |
(958)
|
(683)
|
(1 038)
|
(892)
|
(954)
|
(964)
|
(990)
|
(1 151)
|
|
Selling, General & Administrative |
(851)
|
(668)
|
(1 007)
|
(781)
|
(821)
|
(848)
|
(867)
|
(970)
|
|
Research & Development |
(107)
|
(75)
|
(114)
|
(134)
|
(145)
|
(123)
|
(147)
|
(171)
|
|
Depreciation & Amortization |
(60)
|
(81)
|
(97)
|
(22)
|
(0)
|
(5)
|
0
|
0
|
|
Other Operating Expenses |
59
|
140
|
180
|
44
|
12
|
13
|
24
|
(10)
|
|
Operating Income |
1 523
N/A
|
807
-47%
|
1 498
+86%
|
1 041
-31%
|
1 067
+3%
|
1 106
+4%
|
1 142
+3%
|
1 205
+6%
|
|
Pre-Tax Income | |||||||||
Interest Income Expense |
19
|
10
|
(2)
|
(15)
|
(142)
|
(166)
|
(82)
|
12
|
|
Non-Reccuring Items |
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
1 542
N/A
|
817
-47%
|
1 496
+83%
|
1 026
-31%
|
925
-10%
|
940
+2%
|
1 060
+13%
|
1 217
+15%
|
|
Net Income | |||||||||
Tax Provision |
(128)
|
(63)
|
(120)
|
(103)
|
(92)
|
(85)
|
(107)
|
(95)
|
|
Income from Continuing Operations |
1 414
|
754
|
1 376
|
923
|
833
|
855
|
953
|
1 122
|
|
Net Income (Common) |
1 414
N/A
|
754
-47%
|
1 376
+83%
|
923
-33%
|
833
-10%
|
855
+3%
|
953
+11%
|
1 122
+18%
|
|
EPS (Diluted) |
2.08
N/A
|
1.35
-35%
|
2.03
+50%
|
1.33
-34%
|
1.17
-12%
|
1.21
+3%
|
1.45
+20%
|
1.72
+19%
|